Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Evaluation of Optimized Digital Fundus Reflex Photographs for Lens Opacities in the Age-Related Eye Disease Study 2: AREDS2 Report 7

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Evaluation of Optimized Digital Fundus Reflex Photographs for Lens Opacities in the Age-Related Eye Disease Study 2: AREDS2 Report 7

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Evaluation of a Genomic-Based Prognostic Test for Metastasis in High-Risk Post-Prostatectomy Patients: Does it Impact Physician Decision Making

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Evaluation of a Genomic-Based Prognostic Test for Metastasis in High-Risk Post-Prostatectomy Patients: Does it Impact Physician Decision Making

Authors:

Secondary:

Location:

URL:

Go back to Resources

Circularity Index as a Risk Factor for Progression of Geographic Atrophy

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Circularity Index as a Risk Factor for Progression of Geographic Atrophy

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report

Authors:

Secondary:

URL:

Abstract:

Go back to Resources

Changes in Clearance, Volume and Bioavailability of Immunosuppressants When Given With HAART in HIV-1 Infected Liver and Kidney Transplant Recipients

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Changes in Clearance, Volume and Bioavailability of Immunosuppressants When Given With HAART in HIV-1 Infected Liver and Kidney Transplant Recipients

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

Validation of a Genomic Classifier That Predicts Metastatic Disease Rogression in Men with Biochemical Recurrence Post Radical Prostatectomy

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Validation of a Genomic Classifier That Predicts Metastatic Disease Rogression in Men with Biochemical Recurrence Post Radical Prostatectomy

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with High-Risk Pathologic Features Postprostatectomy

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with High-Risk Pathologic Features Postprostatectomy

Authors:

Secondary:

Location:

URL:

Go back to Resources

Validation of A Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Validation of A Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy

Authors:

Secondary:

Location:

URL:

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an at Risk Patient Population

Submitted by ctuttle on Thu, 05/29/2025 - 08:26
Go back to Resources

Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an at Risk Patient Population

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Current page 210
  • Page 211
  • Page 212
  • Page 213
  • Page 214
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions